1,721,043 research outputs found
Mid-term outcome of reductive Kay annuloplasty of the tricuspid valve in association with mitral valve surgery.
No full textMid-term outcome of reductive Kay annuloplasty of the tricuspid valve in association with mitral valve surgery.. In INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
Nardi, P; Pellegrino, A; Nicolò, F; Zeitani, J; Grego, S; Polisca, P; Scafuri, A; Chiariello, L
DISPOSITIVO PER PLASTICA DELLA VALVOLA MITRALE
No full textDispositivo per plastica della valvola mitrale da impiantarsi in soggetti affetti da valvulopatie causanti stenosi e/o insufficienza, comprendente almeno un corpo curvo, da impiantare complanarmente all’anulus mitralico nativo, caratterizzato dal fatto che detto corpo curvo presenta almeno due porzioni estese
in piani diversi da quello in cui giace detto corpo curvo, atte ad agevolare il
cardiochirurgo nelle riperazioni di riparazione dell’apparato mitralico di un
paziente affetto da stenosi e/o insufficienza, detto corpo curvo presentando
almeno due porzioni discendenti da inserirsi all’interno dell’orifizio mitralico, atte a fornire appiglio per l’ancoraggio di un lembo prolassato e/o di un tessuto biologico biocompatibile con l’organismo umano e/o di elementi tendinei,
quando detto dispositivo è applicato all’apparato mitralico danneggiato di un
paziente
dispositivo di rinforzo sternale post sternotomia o frattura sternale
No full textDispositivo disegnato di garantire stabilita' sternale dopo una sternotomia ed in particolare indicato per pazienti ad alto rischio per deiscenz
sistema a pressione alternante per materasso con doppia concamerazione ad aria ed acqua per la prevenzione delle piaghe da decubito
No full textsistema a pressione alternante per materasso con doppia concamerazione ad aria ed acqua per la prevenzione
delle piaghe da decubito. Il sistema copiuterizzato con possibilita' di controllo unico per piu unita
Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting
No full textSurgical treatment of simultaneous coronary and carotid disease is still controversial, because of the high risk of morbidity and mortality after combined or staged carotid artery endoarterectomy and the coronary artery bypass grafting approach. We report the first 10 patients with concomitant coronary and carotid disease successfully treated with an alternative strategy consisting of simultaneous hybrid revascularization by carotid artery stenting and coronary artery bypass grafting. © 2006 The Society of Thoracic Surgeons
A Surgical Technique to Preserve the Subvalvular Apparatus in Patients Undergoing Mitral Valve Replacement for Severe Ischemic Regurgitation
No full textSevere functional mitral valve regurgitation should be treated in patients undergoing myocardial revascularization. When replacement is considered the best therapeutic option, preservation of the mitral subvalvular apparatus is crucial, especially in the emergency setting, because of its primary role in preserving geometry and function of left and right ventricles. Here we present a simple and quick technique, where subvalvular apparatus is preserved in toto in patients undergoing mitral valve replacement with a bioprosthesis
Simultaneous Hybrid Revascularization with Carotid Stenting and Coronary Artery Bypass Grafting: Long-term Results of the SHARP Study
No full textWe have recently introduced a new therapeutic strategy (“SHARP protocol”) consisting of a simultaneous hybrid revascularization by carotid artery stenting (CAS), immediately followed by coronary artery bypass grafting (CABG) with the aim to reduce operative risk and minimize surgical trauma as compared to traditional approaches. Ninety-five consecutive patients (mean age 68.87.8 years, 79 males,) underwent simultaneous CAS-CABG from January 2005 to July 2013 for treatment of concomitant critical (>70% stenosis) carotid and multivessel coronary artery obstructive disease. In-hospital mortality was 2.1%, perioperative myocardial infarction 0%, CAS periprocedural stroke 0%, TIA 3.2%. Actuarial 9-year survival was 8210%. Freedom from cardiac death was 962%, from myocardial infarction 953%, from neurological events 907%, from CAS procedure-related stroke 100%. The proposed hybrid approach confers a mortality rate comparable to that of isolated CABG; CABG immediately following CAS minimizes the risk of periprocedural myocardial infarction. At a long-term period a high rate of event-free survival and freedom from neurological events can be expected using the SHARP protocol
Hybrid Approach to Treat Total Thoracic Aortic Aneurysm in a Patient Undergoing Emergency Surgery for Descending Aortic Rupture
No full textRupture of the descending aorta is a life-threatening complication requiring emergency intervention. The endovascular approach (TEVAR) has been recently introduced to treat the descending aorta in the emergency setting, resulting in better early postoperative outcome as compared with traditional surgery. However, when the pathology involves the aortic arch and ascending aorta, TEVAR alone cannot be performed, requiring an alternative approach. We describe a one-stage hybrid repair via midline sternotomy to treat rupture of the descending thoracic aortic segment in toto
Mini-extracorporeal circulation minimizes coagulation abnormalities and ameliorates pulmonary outcome in coronary artery bypass grafting surgery
No full textHemostasis is impaired during CABG and coagulation abnormalities often result in clinically relevant organ dysfunctions, eventually increasing morbidity and mortality rates. Fifteen consecutive patients with coronary artery disease submitted to conventional extracorporeal circulation (cECC) have been compared with 15 matched patients, using mini-ECC (MECC). Postoperative lung function was evaluated according to gas exchange, intubation time and lung injury score. In the MECC group, thrombin-antithrombin complex levels (TaTc), prothrombin fragments (PF1+2) formation and thromboelastography (TEG) clotting times were lower compared to the cECC group (p=0.002 and p<0.001, respectively) whereas postoperative blood loss was higher in the cECC group (p=0.030) and more patients required blood transfusion (p=0.020). In the MECC group, postoperative gas exchange values were better, intubation time shorter and lung injury score lower (p<0.001 for all comparisons). Our study suggests that MECC induces less coagulation disorders, leading to lower postoperative blood loss and better postoperative lung function. This approach may be advantageous in high-risk patients. © The Author(s) 2013
- …
